Jason Gotlib
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Hematology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Hematology Clinic 875 Blake Wilbur Dr Clinic C Stanford, CA 94305-5820 Tel Work (650) 498-6000 Fax (650) 498-5030
Professional Snapshot
Clinical Focus
- Cancer > Hematology
- Hematology
Honors and Awards
- NIH K23 Mentored Patient-Oriented Research Career Development Award (#HL04409), National Institutes of Health (2001-2006)
- Hematology Division Faculty Teaching Award, Stanford Division of Hematology/Department of Medicine (2005, 2007, 2009)
- Charles Dorsey Armstrong Award for Excellence in Patient Care, Stanford Internal Medicine Residency Program (1998)
Professional Education
| Board Certification: | Hematology, American Board of Internal Medicine (2001) |
| Fellowship: | SUMC - Graduate Medical Education, CA (2003) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2002) |
| Residency: | SUMC - Graduate Medical Education, CA (1998) |
| Internship: | SUMC - Graduate Medical Education, CA (1996) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Research Interests
My research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:
--Myelodysplastic syndromes (MDS)
--Chronic myelogenous leukemia (CML)
--Acute myelogenous leukemia (AML)
--Myeloproliferative disorders (MPDs) including:
Hypereosinophilic syndrome
Systemic mastocytosis
BCR-ABL-negative MPDs
Clinical Trials
- Phase II PKC412 in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Recruiting
- A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients Recruiting
- Allogeneic HCT using Nonmyeloablative Host Conditioning with TLI & ATG vs SOC in AML Recruiting
- An Open-Label, Dose Escalation, Phase 1 Study of MLN4924, a Novel Inhibitor of Nedd8-Activating Enzyme, in Adult Patients with Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome Recruiting
- Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Recruiting
Publications
- When yellow jackets attack: Recurrent and severe anaphylactic reactions to insect bites and stings. Am J Hematol. 2009; (12): 843-846
- Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci U S A. 2009; (10): 3925-9
- RNAi screen for rapid therapeutic target identification in leukemia patients. Proc Natl Acad Sci U S A. 2009; (21): 8695-700
- Monoclonal antibodies against IREM-1: potential for targeted therapy of AML. Leukemia. 2009; (9): 1587-97
- On being metachromatic: Mystique and misunderstanding in mastocytosis. Am J Hematol. 2009; (12): 779-781
Help